Another nail in the hammer's coffin?

Blood pressure saggy? Cardiac output low? Oliguria? Increasing acidosis? Peripheries a bit cool? Poor cardiac history? No problem. Just start some dobutamine and watch the numbers improve. And if the patient happens to die, that is their fault. Or is it? Catecholamines are long-established drugs tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Mervyn, Brealey, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387607/
https://www.ncbi.nlm.nih.gov/pubmed/21888684
http://dx.doi.org/10.1186/cc10311
_version_ 1782237107125747712
author Singer, Mervyn
Brealey, David
author_facet Singer, Mervyn
Brealey, David
author_sort Singer, Mervyn
collection PubMed
description Blood pressure saggy? Cardiac output low? Oliguria? Increasing acidosis? Peripheries a bit cool? Poor cardiac history? No problem. Just start some dobutamine and watch the numbers improve. And if the patient happens to die, that is their fault. Or is it? Catecholamines are long-established drugs that have never undergone formal testing of long-term outcomes and safety. Their use requires re-evaluation in the light of a wide range of deleterious actions and retrospective studies suggesting harm.
format Online
Article
Text
id pubmed-3387607
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33876072012-08-08 Another nail in the hammer's coffin? Singer, Mervyn Brealey, David Crit Care Commentary Blood pressure saggy? Cardiac output low? Oliguria? Increasing acidosis? Peripheries a bit cool? Poor cardiac history? No problem. Just start some dobutamine and watch the numbers improve. And if the patient happens to die, that is their fault. Or is it? Catecholamines are long-established drugs that have never undergone formal testing of long-term outcomes and safety. Their use requires re-evaluation in the light of a wide range of deleterious actions and retrospective studies suggesting harm. BioMed Central 2011 2011-08-08 /pmc/articles/PMC3387607/ /pubmed/21888684 http://dx.doi.org/10.1186/cc10311 Text en Copyright ©2011 BioMed Central Ltd
spellingShingle Commentary
Singer, Mervyn
Brealey, David
Another nail in the hammer's coffin?
title Another nail in the hammer's coffin?
title_full Another nail in the hammer's coffin?
title_fullStr Another nail in the hammer's coffin?
title_full_unstemmed Another nail in the hammer's coffin?
title_short Another nail in the hammer's coffin?
title_sort another nail in the hammer's coffin?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387607/
https://www.ncbi.nlm.nih.gov/pubmed/21888684
http://dx.doi.org/10.1186/cc10311
work_keys_str_mv AT singermervyn anothernailinthehammerscoffin
AT brealeydavid anothernailinthehammerscoffin

Ejemplares similares